According to a recent market analysis conducted by Future Market Insights (FMI), the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market was valued at US$ 3.8 billion in 2021 and is anticipated to reach US$ 5.5 billion by 2030.Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocardit.